RenovoRx
present chemotherapy regimens have limited efficacy in tumors inability to penetrate tumor tissue | RenovoRx
Company
Deck Type
IPO
Deck date
August 2021
Slide
7 of 29
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io